Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2019 13F Holders as of 30 Jun 2019
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 11,679,733
- Total 13F value
- $35,039,000
- Share change
- +16,932
- SEC-reported price per share
- $3.00
- Number of holders
- 10
- Value change
- +$50,902
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 140,036,400
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
10
Top holders
10
XTNT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Ownership snapshot
Top reported holders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
9/10
Latest evidence
31 Mar 2019
13F
Lead comparable stake: 6.6%
1 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 6.6%.
9 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
6.6%
Park West Asset Management LLC
0.9%
Telemetry Investments, L.L.C.
0.55%
VANGUARD GROUP INC
0.21%
RENAISSANCE TECHNOLOGIES LLC
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
6.6%
|
$28,081,000
9,207,012 shares
|
— | 31 Mar 2019 |
| Park West Asset Management LLC |
13F
Company
|
0.9%
|
$3,839,000
1,258,733 shares
|
— | 31 Mar 2019 |
| Telemetry Investments, L.L.C. |
13F
Company
|
0.55%
|
$2,345,000
768,913 shares
|
— | 31 Mar 2019 |
| VANGUARD GROUP INC |
13F
Company
|
0.21%
|
$882,000
289,252 shares
|
— | 31 Mar 2019 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.05%
|
$205,000
67,161 shares
|
— | 31 Mar 2019 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.04%
|
$153,000
50,000 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
11,679,733
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
9
Q2 2019 holders
10
Holder diff
1
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend